HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
188 ^CHF	0.00%		0.00%	+2.96%

Apr. 03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
Jan. 22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

HBM Healthcare Investments Media Release

September 05, 2018 at 11:40 am EDT

Media Release

Zug, 5 September 2018

HBM Healthcare Investments takes USD 15 million stake in China's Leading Online Pharmacy and Healthcare Services Platform Jianke

Jianke, a privately held company based in Guangzhou, China, today announced the closing of a USD 130 million financing round. HBM Healthcare Investments participated with USD 15 million in this financing.

Jianke was founded in 2006 and is the largest online B2C pharmacy and healthcare services platform in China. The company has served more than 100 million customers in China by offering 680'000 stock keeping units (SKUs) and its healthcare advisory services.

Contact

For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at andreas.wicki@hbmhealthcare.com.

HBM Healthcare Investments takes USD 15 million stake in China’s Leading Online Pharmacy and Healthcare Services Platform Jianke

Provider		Channel		Contact
Tensid EQS Ltd., Switzerland www.tensid.ch		newsbox.ch www.newsbox.ch		Provider/Channel related enquiries cs@tensideqs.ch +41 41 763 00 50

Latest news about HBM Healthcare Investments AG

HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	Apr. 03	MT
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	Jan. 22	MT
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	Jan. 04	MT
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT
HBM Healthcare Investments Launches Share Buyback	23-10-16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	23-10-16	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	23-10-16	CI
HBM Healthcare Investments Flags Fiscal H1 Loss	23-10-03	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-21	CI
HBM Healthcare Investments' Ficsal Q1 NAV Per Share Declines	23-07-21	MT
HBM Healthcare Investments AG commences an Equity Buyback Plan under the authorization approved on June 10, 2022.	23-07-05	CI
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	23-06-14	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-26	CI
HBM Healthcare Investments' Loss Widens in FY23	23-05-12	MT
HBM Healthcare Investments Posts 3% Drop in April NAV	23-05-02	MT
HBM Healthcare Invests $12 Million into US-based ArriVent Biopharma	23-03-28	MT
HBM Healthcare Investments CEO Set to Resume Duties After Health Issues	23-03-28	MT
HBM Healthcare Investments' Portfolio Company Mineralys Therapeutics Completes $192 Million IPO	23-02-13	MT
HBM Healthcare Investments CEO Takes Temporary Leave of Absence	23-01-30	MT
Nicox: HBM Healthcare Investments falls below 5% threshold	23-01-23	CF
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-20	CI

Chart HBM Healthcare Investments AG

Duration

Period

More charts

Company Profile

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Sector

Investment Management & Fund Operators

Calendar

2024-05-07 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for HBM Healthcare Investments AG

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

188 CHF

Average target price

236 CHF

Spread / Average Target

+25.53%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+2.96%	1.42B
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+15.00%	3.04B
CION INVESTMENT CORPORATION	+0.66%	611M
VERUSA HOLDING	+35.79%	565M
MOLTEN VENTURES PLC	-10.84%	558M
OCTOPUS APOLLO VCT PLC	-4.17%	493M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+33.85%	493M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	305M
BITCOIN GROUP SE	+65.35%	284M

Venture Capital